aids vaccine trial

BANGKOK – For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. Recent failures led many scientists to think such a vaccine might never be possible. The World Health Organization and the U.N. agency UNAIDS said the results "instilled new hope" in the field of HIV vaccine research.

Vaccine Campaigns May Be The Cause of New AIDS-Like Disease in Asia and Drug Resistant HIV Affecting Africa Researchers have identified mysterious new symptoms that have left scores of people in Asia and sub-Saharan Africa with an AIDS-like disease and drug-resistant HIV respectively. Coincidentally, vaccine trials took place in several regions in both continents. The patients' immune systems become damaged, leaving them unable to fend off germs as healthy people do.

The Bangladesh trial used treatment naive patients, about 160, and treatment was vaccine only or pegasys. It was not reported in the available abstract how many were eag pos or neg. I would assume it was a mix. The e ag pos have a much better chance for a stabilizing response.

FR0012333284 – ABVX), an emerging leader in developing and commercializing anti-viral and vaccine therapies for diseases like HIV/AIDS and chronic Hepatitis B (CHB) and the Center for genetic Engineering and Biotechnology (CIGB), a global leader in biotechnology, today announced that CECMED, the Cuban regulatory authorities, granted the CIGB their first marketing authorization application for ABX203, a first-in-class therapeutic vaccine for treatment of CHB, under the trade name HeberNasvac.

Dear Vance,teak,howardh,nursegirl and all the experts of the forum few days ago i was having a normal discussion over the HIV topic with few of the medical representatives and they were saying that now a days medical science is so advance that a cure for hiv and AIDS is there but medicine giants are not issuing it out just because a huge amount of money they have invested in treatment of HIV and AIDS so they are restricted to reveal it for the public interest whereas few were saying that cure o

Thhts good to know. I may have to look in to %. The one thing I didnt even think of. Thankyou. And I do partially agree with what your saying but vaccines are being changed constantly and I believe that just because something works for one peraon without causing issues I still believe there is an opposite effect to others. I believe everyone has been a 'guinea pig' at one stage or another. Look at the food society consumes. ..

What does a 2/3 trial seek to establish? Thanks.

I do not know anything about a possible Hcv vaccine. wasn't aware that a vaccine was on the radar at the present time.

The next research study is sponsored by AiCuris, a German company. This is a phase 2 trial, the phase 1 trial complete two years ago. The results of the phase 1 trial indicate that this oral medicine has excellent activity against the herpes virus. The newest study will compare the AiCuris drug against Valtrex, an FDA approved medicine for the treatment of genital herpes. For more information about research sites conducting this study, please contact AiCuris.

Hi Will, as it happens l have an appointment with a Dr at the trial hospital tomorrow. I will ask him about this trial. I don't know if l will qualify as the only treatment l had is a failed go (4 week duration) go at the 3 drug combo incivik.

I have had an unprotected intercourse with someone who is a participant in an HIV vaccination trial at Walter Reed. What exactly is that study as I am having a hard time finding info on it. Do they use surface antigens? Am I at any risk? Any info will be appreciated. Sincerely, Ivan.

rank=1 is a Phase 2b/3 clinical trial of ABX203 the therapeutic vaccine first developed in Cuba. Official Title: Phase IIB-III Efficacy Study of ABX203 Vaccine as an Adjunct Therapy to Nucleos(t)Ide Analogs to Maintain Control of HBV Replication After Cessation of Treatment in HBeAg Negative Patients With Chronic Hepatitis B.

com Inovio Biomedical Corporation INO, a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB of Sweden, received approvals from the Swedish Medical Products Agency and local ethics committees to initiate a Phase I/II clinical trial of a novel DNA vaccine designed to treat chronically infected hepatitis C virus (HCV) patients.

The clinical trial Phase II-III is ending. The vaccine is not registered yet for general use. Clinical trials are ongoing in Cuba and Bangladesh and new trials should start in Brazil and Europe next year. (I just copy a part of the study document, it is quite big file) The nasal vaccine candidate (NASVAC), comprising hepatitis B virus (HBV) surface (HBsAg) and core antigens (HBcAg), has been shown to be highly immunogenic in animal models.

I just recently enrolled in the abagovamab vaccine trial at Memorial Sloan Kettering in NYC. I think clinical trials are important and urge everyone who can particiapte to consider trials in hopes of finding better treatments for this horrible disease.

A friend of mine is finished with her chemo but is trying to enroll in a special trial in Buffalo, NY. Somehow they give her a single chemo drug plus this other stuff that targets just the cancer cells and kills them. Wish I had more information on it. The thing is she would have to fly to Buffalo for 4 days each month for 4 months to receive the treatment. But she's excited about it, just not sure of the details or timing yet. Anyone know about this?

They now have the Cervical Cancer Vaccine ( Gardasil) and are working on an OVCA vaccine. They are in the second trial and need one more before the FDA approves. By giving it to patients with OVC in recurrence, they have prevented it from returning for two years. They are tweeking that and want total prevention. They have also been successful with prostrate cancer and as you heard last week, skin cancer. It does not seem that OVC patients are very vocal for our cause.

the best vaccine type must contain hbcag, can you check that?

The results of the combined intranasal and parentral use of this mix in chronic HBV patients were also published in the 2013 AASLD abstracts. They were much better than any other therapeutic vaccine trial before.ABIVAX is now pursuing the further development of this combo vaccine. Discuss and coordinate everything with your doctor.

Aids vaccine trial

Common Questions and Answers about Aids vaccine trial

aids